| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |